5 Canadian Stocks Surging 100%+ During the Past Month

Share on Linkedin

The Canadian stocks on our list have doubled or more this past month, and the momentum may continue

SmallCapPower | April 18, 2017: Today we have identified five Canadian stocks that have DOUBLED—if not more—in price in the past month. Backed by a rally supported by heavier-than-normal volume, the companies on our list have support to head even higher.

Win Big With Our Small Cap Picks

 

Hydropothecary Corp. (TSXV: THCX) – $2.32
Pharmaceuticals

Hydropothecary Corp, formerly BFK Capital Corp, is a Canada-based company, which is an authorized licensed producer and distributor of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company provides naturally and rigorously tested medical marijuana, grown without the use of synthetic pesticides in greenhouses. In addition to medical marijuana production and sales, the Company explores research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry.

  • Market Cap: $175.9 million
  • 1 Month Total Return: 243.7%
  • Avg Volume (12 months): 111,846
  • Avg Volume (last 30 days): 931,606

Wildflower Marijuana Inc. (CSE: SUN) – $0.83
Pharmaceuticals

Wildflower Marijuana Inc., formerly Sunorca Development Corp, is a Canada-based cannabis company. The Company focuses on developing and designing products in the cannabis and healthcare sectors. Wildflower Marijuana Inc develops product lines using tetrahydrocannabinol (THC) or cannabidiol (CBD) by taking traditional herbal medicines and applying science and technology to create products for consumers.

  • Market Cap: $36.5 million
  • 1 Month Total Return: 207.4%
  • Avg Volume (12 months): 164,218
  • Avg Volume (last 30 days): 664,207

Kenadyr Mining Corp. (TSXV: KEN) – $0.84
Gold

Kenadyr Mining Corp is a Canada-based company engaged in the exploration of the historic, high-grade, Borubai gold project located in the Kyrgyz Republic in Central Asia. The Company holds approximately 100% interest in the 164 square kilometers Borubai Exploration License, which encircles Zijin’s Taldybulak Levoberejnyi Mine (TBL Mine), a newly built and producing mine containing approximately 3.2 million ounces in reserves and resources at a grade of 7.2 g/t. The Borubai Project has had 81,800 meters of historic drilling and is only 100 km, from Bishkek, the capital of the Kyrgyz Republic.

  • Market Cap: $70.5 million
  • 1 Month Total Return: 180.0%
  • Avg Volume (12 months): 8,851
  • Avg Volume (last 30 days): 73,583

Mood Media Corp. (TSX: MM) – $0.17
Advertising & Marketing

Mood Media Corporation provides in-store audio, visual, mobile, voice, drive thru, commercial television, social and scent marketing solutions. The Company’s segments include In-Store Media North America, In-Store Media International, BIS and Other. Its businesses include specialist retailers, department stores, supermarkets, financial institutions and fitness clubs, as well as hotels, car dealerships and restaurants. Its In-store media-North America’s operations are based in the United States, Canada and Latin America.

  • Market Cap: $30.5 million
  • 1 Month Total Return: 135.7%
  • Avg Volume (12 months): 282,956
  • Avg Volume (last 30 days): 367,804

InMed Pharmaceuticals Inc. (CSE: IN) – $0.77
Biotechnology & Medical Research

InMed Pharmaceuticals Inc. is a pre-clinical-stage biopharmaceutical company that specializes in the research and development of cannabinoid-based therapies combined with drug delivery systems. The Company operates through the segment of research and development of pharmaceutical cannabis based-therapies. The Company is working on two products, which include INM-750, for the treatment of Epidermolysis Bullosa (EB), and INM-085, for the treatment of Glaucoma. The INM-750 is a therapy developed for EB designed specifically to modulate disease activity and to alleviate symptoms. The INM-085 is designed as a dual-action cannabinoid ocular therapy. INM-085 is designed as a topical formulation to be administered directly to the eye.

  • Market Cap: $83.4 million
  • 1 Month Total Return: 113.9%
  • Avg Volume (12 months): 523,619
  • Avg Volume (last 30 days): 1,012,143

Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: